Gynecologic cancers are cancers that begin in a woman’s reproductive organs. The most common ones in Indonesia are cervical cancer, ovarian cancer, and uterine (womb) cancer.
Among these, cervical cancer is the most common, followed by ovarian and uterine cancers. These cancers can be serious, but when found early, they are often treatable.
Unfortunately, many cases in Indonesia are detected too late, when treatment becomes more difficult and survival chances are lower. At Bali International Hospital, we aim to raise awareness and encourage early detection so that more women can get the care they need on time.
In this article, we will provide you with important information about these types of cancers, their risk factors, symptoms, and most importantly, how early detection through screening can save lives.
Cancers grow slowly and may not show clear symptoms at first. This is why regular screening and early detection are so important.
When cancer is found in its early stages, treatment can be more effective, recovery is faster, and the chances of survival are much higher. However, in Indonesia, many women still do not get regular checkups because of a lack of awareness, limited access to healthcare, or fear of diagnosis.
It’s important for every woman to understand that early detection saves lives and that screenings are simple, safe, and available in many health centers.
Cervical cancer happens when cells in the cervix (the lower part of the uterus) grow abnormally. The main cause is Human Papillomavirus (HPV) infection, especially types 16 and 18, which cause about 82% of invasive cervical cancer cases.
In Indonesia, the primary screening method for cervical cancer is VIA (Visual Inspection with Acetic Acid). It is an affordable, quick, and easy-to-perform test, even in small clinics or rural areas.
During the VIA test, a small amount of vinegar (acetic acid) is applied to the cervix. If there are abnormal cells, they turn white and can be seen with the naked eye.
Unfortunately, screening rates are still low. As of 2018, only about 3% of women aged 30-50 years had been screened.
This means many women who could benefit from early detection are missing out. Aside from VIA, there are other important tests used for cervical cancer screening:
Along with screening, HPV vaccination plays a big role in preventing cervical cancer. The vaccine protects against the types of HPV that cause most cervical cancers.
Getting vaccinated and having regular VIA or Pap smear tests can dramatically lower your risk.
Ovarian cancer is often called the “silent killer” because it usually doesn’t show clear symptoms in its early stages. Many women only realize something is wrong when the cancer has already spread, which makes it harder to treat.
There is no simple or routine test for early ovarian cancer, like there is for cervical cancer. Diagnosis often depends on imaging tests such as ultrasound, CT scan, MRI, or PET scan, which are usually done only after symptoms appear.
Common symptoms can include bloating, frequent urination, abdominal pain, or feeling full quickly, but these can be mistaken for common digestive issues. Because of this, about 65-75% of ovarian cancer cases in Indonesia are diagnosed at a late stage.
Gynecologists in Indonesia use specific scoring systems to decide when a patient needs referral to a specialist. However, there is still a shortage of gynecologic oncologists (cancer specialists), especially outside major cities.
This makes it harder for some women to get an early and accurate diagnosis. Improving access to specialists and raising awareness about the symptoms of ovarian cancer can help women seek care sooner and increase their chances of recovery.
Uterine cancer, also known as cancer of the womb, usually affects women between 45 and 54 years old. It often begins with the lining of the uterus.
Risk factors include:
The good news is that uterine cancer often shows early signs, such as abnormal vaginal bleeding, for example, bleeding after menopause or between periods. If you notice these symptoms, it’s important to see a doctor as soon as possible.
When diagnosed early, uterine cancer can be treated effectively, often with surgery or other targeted treatments.
Indonesia faces unique challenges in providing equal healthcare access across its many islands. The national health insurance system (BPJS) uses a tiered referral process, where patients first go to a primary health center and then get referred to hospitals or specialists if needed.
Because of this system, OB-GYN doctors (obstetricians and gynecologists) play a very important role. They are often the first to notice early signs of gynecologic cancer and can guide patients toward further tests or specialist care.
Strengthening early detection at the community level is key to saving more lives.
At our hospital, we provide comprehensive gynecologic care, from regular checkups and early detection to treatment and ongoing support. Our team includes experienced obstetricians, gynecologists, and oncology specialists who work together to provide personalized care in a comfortable and professional environment.
We use advanced medical technology to ensure accurate diagnosis and effective treatment. More importantly, we focus on making every woman feel supported and informed throughout her care journey.
If you are due for a screening, have unusual symptoms, or simply want to learn more about protecting your reproductive health, our team is ready to help.
Gynecologic cancer testing includes:
In Indonesia, VIA (Visual Inspection with Acetic Acid) is the most common method for cervical cancer. Vinegar is applied to the cervix, and abnormal cells turn white.
Other tests include Pap smear and HPV-DNA testing. For ovarian cancer, doctors use ultrasound, CT scans, and CA-125 blood tests, while uterine cancer is diagnosed through biopsy and ultrasound.
Recently, self-collection HPV tests have become available, helping women test themselves easily for early detection.
In Indonesia, women aged 30-50 years are encouraged to have cervical cancer screening. The VIA test is the main method because it’s simple and affordable.
Pap smears can be done every 3–5 years, while HPV-DNA tests are more sensitive but not yet widely available. Women with positive test results are referred for further care.
HPV vaccination is also strongly recommended as a preventive measure, aiming for 90% coverage to reduce future cervical cancer cases.
Female cancer screening means regular health checks to find cancers early, especially cervical, ovarian, and uterine cancers, before symptoms appear. The goal is to detect problems early, when treatment works best.
Common screening tests include:
Effective screening helps lower cancer risk and improve survival rates, especially when combined with HPV vaccination and early treatment.
The main cervical cancer screening methods are:
Each method has different costs and accuracy levels, but VIA remains the most practical and accessible option in Indonesia. Together, these screening options, along with HPV vaccination and timely treatment, form Indonesia’s main approach to reducing gynecologic cancer cases and improving women’s health outcomes.
Early detection of gynecologic cancers can make all the difference. By understanding the symptoms, getting regular screenings, and seeking medical advice early, women can significantly improve their chances of recovery.
At our international hospital, we’re here to provide the right care at every step. Whether you need a cervical cancer screening, a hormone test for women in Bali, or a full gynecologic consultation, our doctors are here to guide you.
We also provide emergency services if you ever need urgent help. You can rely on our emergency hospital ambulance in Denpasar for fast and professional assistance.
For more information or to book a consultation, contact us today. Together, let’s take proactive steps toward better women’s health and a cancer-free future.